Literature DB >> 18719172

Acanthamoeba and the blood-brain barrier: the breakthrough.

Naveed Ahmed Khan1.   

Abstract

Acanthamoeba granulomatous encephalitis is a rare disease that almost always proves fatal. Death occurs mainly due to neurological complications; however, the pathogenesis and pathophysiology associated with this disease remain incompletely understood. Haematogenous spread is a key step in the development of Acanthamoeba encephalitis, but it is not clear how circulating amoebae breakthrough the blood-brain barrier to gain entry into the central nervous system to produce the disease. This review of the literature describes the parasite factors and immune-mediated mechanisms involved in the blood-brain barrier dysfunction leading to neuropathogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18719172     DOI: 10.1099/jmm.0.2008/000976-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

Review 1.  Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.

Authors:  Max N Brondfield; Michael J A Reid; Rachel L Rutishauser; Jennifer R Cope; Jevon Tang; Jana M Ritter; Almea Matanock; Ibne Ali; Sarah B Doernberg; Alexandra Hilts-Horeczko; Teresa DeMarco; Liviu Klein; Jennifer M Babik
Journal:  Transpl Infect Dis       Date:  2017-03-06       Impact factor: 2.228

2.  An Unusual Cause of Central Nervous System Infection During Acute Myeloid Leukemia Induction Chemotherapy: Acanthamoeba Brain Abscess.

Authors:  Ram V Nampoothiri; Pankaj Malhotra; Ankur Jain; Nitya Batra; Kirti Gupta; Fen Saj; Sumeeta Khurana; Harsha Mahalingam; Anupam Lal; Kanchan Mukherjee; Bishan Radotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-05-05       Impact factor: 0.900

3.  Acanthamoeba culbertsoni elicits soluble factors that exert anti-microglial cell activity.

Authors:  Jenica L Harrison; Gabriela A Ferreira; Erinn S Raborn; Audrey D Lafrenaye; Francine Marciano-Cabral; Guy A Cabral
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

Review 4.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

5.  Acanthamoeba produces disseminated infection in locusts and traverses the locust blood-brain barrier to invade the central nervous system.

Authors:  Parisa N Mortazavi; Graham Goldsworthy; Ruth Kirk; Naveed A Khan
Journal:  BMC Microbiol       Date:  2010-07-08       Impact factor: 3.605

6.  The role of Src kinase in the biology and pathogenesis of Acanthamoeba castellanii.

Authors:  Ruqaiyyah Siddiqui; Junaid Iqbal; Marie-Josée Maugueret; Naveed Ahmed Khan
Journal:  Parasit Vectors       Date:  2012-06-07       Impact factor: 3.876

7.  A morphological approach to the diagnosis of protozoal infections of the central nervous system.

Authors:  Leila Chimelli
Journal:  Patholog Res Int       Date:  2011-07-14

8.  Fatal acanthamoeba encephalitis in a patient with a total artificial heart (syncardia) device.

Authors:  Susanna K Tan; Kiran Gajurel; Christie Tung; Gregory Albers; Stan Deresinski; Jose G Montoya; Ahmad Y Sheikh; Dipanjan Banerjee; Richard Ha
Journal:  Open Forum Infect Dis       Date:  2014-08-19       Impact factor: 3.835

9.  Fatal Granulomatous Amoebic Encephalitis Caused by Acanthamoeba in a Patient With Kidney Transplant: A Case Report.

Authors:  Ahmad Salameh; Nancy Bello; Jennifer Becker; Tirdad Zangeneh
Journal:  Open Forum Infect Dis       Date:  2015-07-10       Impact factor: 3.835

10.  SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens.

Authors:  Chandirasegaran Massilamany; Francine Marciano-Cabral; Bruno da Rocha-Azevedo; Melissa Jamerson; Arunakumar Gangaplara; David Steffen; Rana Zabad; Zsolt Illes; Raymond A Sobel; Jay Reddy
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.